|
Cepheid - Company Profile Snapshot
| Company Profile: |
Cepheid |
| Ticker: |
CPHD |
| Exchanges: |
NAS |
| 2008 Sales: |
169,630,000 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Medical, Surgical & Dental Suppliers |
| Country: |
UNITED STATES |
| Employees: |
547 |
Business Description
Cepheid. The Group's principal activity is to develop, manufacture and market fully integrated systems for testing in the Clinical market, as well as for application in legacy Biothreat and Industrial markets.These systems systems enable rapid, sophisticated molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The products include Smart Cycler (R), a DNA amplification and detection system and the GeneXpert(R) system, that combines sample preparation with the amplification and detection functions of the Smart Cycler. The Group markets its products in North America, Europe, Japan and other countries.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
